In a report released on January 29, Michael Cherny from Leerink Partners reiterated a Hold rating on Henry Schein (HSIC – Research Report), ...

Securities updated their financial outlook on Henry Schein (NASDAQ:HSIC), increasing the price target to $78 from the previous $75, while maintaining a Neutral rating on the company's stock. According ...

Barrington analyst Michael Petusky raised the firm’s price target on Henry Schein (HSIC) to $90 from $82 and keeps an Outperform rating on the ...

Henry Schein Inc. closed 3.34% below its 52-week high of $82.63, which the company achieved on February 27th.

Henry Schein receives $250 million strategic investment from KKR, making them largest non-index fund shareholder.

KKR is set to become the largest non-index fund shareholder in Henry Schein, acquiring a 12% stake through a $250 million investment.

Henry Schein announced today that private equity firm KKR is investing $250 million in the medical products manufacturer and ...

Shares of Henry Schein (NASDAQ:HSIC) traded higher in the premarket on Wednesday after The Wall Street Journal reported that the private equity firm KKR (NYSE:KKR) has built a significant stake in the ...

KKR & Co. has taken a 12% stake in Henry Schein Inc. and will work with the company to improve operations at the world’s ...

Henry Schein said it expects to report earnings and revenue growth in the fourth quarter and forecast further gains in 2025 adjusted earnings, even as it confirmed an activist-investment deal with ...

Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today announced it has completed the acquisition of ...

MELVILLE, N.Y., January 15, 2025--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today ...